A Major Medical Journal Refused to Pull a Study on Vaccine Safety. Here's Why It Matters.

A prestigious medical journal called the Annals of Internal Medicine said no to Health and Human Services Secretary Robert F. Kennedy Jr. when he asked them to retract a study about vaccines. The journal's editor-in-chief stated there was "no reason" to remove the paper, Reuters reported on August 11, 2025.

What the Study Found

The Danish study looked at health records from 1.2 million people. Its conclusion: aluminum compounds used in vaccines do not increase health risks in children. Aluminum salts are common in vaccines worldwide — they work like a booster that helps your immune system respond better, which means doctors can use smaller doses of the active ingredient. According to HealthExec, Kennedy asked for the paper to be retracted, but the journal declined.

How Retractions Actually Work

When a journal pulls a published paper, it's a formal process with clear reasons. They remove papers when they find that the researchers made up data, manipulated their results, or made a major error. A public official disagreeing with the conclusions is not one of those reasons. The journal's refusal follows the standard rules, and the editor was direct about it.

Why This Moment Matters

Kennedy holds two roles that are now in tension: he has long questioned vaccine safety, and he now heads the department that oversees the CDC, FDA, and NIH — the agencies that fund and conduct vaccine research. This creates an unusual situation. When a sitting cabinet secretary asks a scientific journal to retract a study, researchers and editors pay attention. They worry about whether political pressure could influence the independence of science.

Kennedy has no direct power over scientific journals. But he does control the money. The National Institutes of Health gives grants, the CDC makes contracts, and the Department of Health and Human Services sends funding to universities and research institutions. Those same institutions are where researchers publish their work. The question now is whether that funding power could be used as leverage.

For the broader scientific publishing world, what the Annals did was routine: they rejected an unsupported request to retract a study. Journals get pressure from many quarters — industry groups, governments, advocacy organizations. What is unusual here is that the pressure came from a U.S. cabinet secretary with jurisdiction over the very agencies that fund the research system journals depend on.

How Kennedy responds next is still an open question. Whether he tries to use his control over funding as a way to reshape how science is reviewed, and whether Congress or other institutions step in if he does, will reveal something important about how independent science can remain under this administration.